207_Combined course Presentations

Residual disease after neoadjuvant CT

Standard

Malattia residua

R

Chemio

Chirurgia

Standard Rx + capecitabina

(n=900, 296 TNBC)

5yr DFS

74 v 68%

All patients

89 v 84% 5yr OS

HR 0.70 (0.53-0.93)

1-sided p<0.01 HR 0.60 (0.40-0.92)

1-sided p=0.00524 < 0.00671

36